Nakagawa Hidetoshi 中河秀俊

… Alternative Names

中河秀俊ナカガワヒデトシ

Less

Researcher Number	90743469
Other IDs	https://orcid.org/0000-0002-3657-7405
Affiliation (Current)	2024: 金沢大学, 附属病院, 助教
Affiliation (based on the past Project Information) *help	2022 – 2023: 金沢大学, 医学系, 助教 2020 – 2021: 金沢大学, 附属病院, 特任助教 2015: 金沢大学, 医学系, 研究員
Review Section/Research Field	Principal Investigator Basic Section 53010:Gastroenterology-related / 0803:Pathology, infection/immunology, and related fields / Gastroenterology
Keywords	Principal Investigator がん免疫 / 肝細胞癌 / TCR遺伝子治療 / MRP3 / AFP / 免疫療法 / アルファフェトプロテイン / TERT / TCR-T / 養子免疫療法 … More / T細胞 / ペプチドーム / 肝がん / 免疫 / 非古典的主要組織適応抗原複合体 / HLA-E Less

Research Projects
(3 results)
Research Products
(8 results)

Combination of T cell receptor gene therapy and immune checkpoint blockadePrincipal Investigator
- Principal Investigator
  
  中河秀俊
- Project Period (FY)
  2022 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 53010:Gastroenterology-related
- Research Institution
  Kanazawa University
Antitumor immunity mediated by HLA-E in hepatocellular carcinomaPrincipal Investigator
- Principal Investigator
  
  Nakagawa Hidetoshi
- Project Period (FY)
  2020 – 2022
- Research Category
  
  Grant-in-Aid for Research Activity Start-up
- Review Section
  
  0803:Pathology, infection/immunology, and related fields
- Research Institution
  Kanazawa University
肝臓がん遺伝子治療用T細胞受容体の選択と機能評価Principal Investigator
- Principal Investigator
  
  中河秀俊
- Project Period (FY)
  2015 – 2017
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Gastroenterology
- Research Institution
  Kanazawa University

All 2023 2022 2021

All Journal Article Presentation

[Journal Article] Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8+ T cells2022
- Author(s)
  Mizukoshi Eishiro、Nakagawa Hidetoshi、Tamai Toshikatsu、Kitahara Masaaki、Fushimi Kazumi、Nio Kouki、Terashima Takeshi、Iida Noriho、Arai Kuniaki、Yamashita Tatsuya、Yamashita Taro、Sakai Yoshio、Honda Masao、Kaneko Shuichi
- Journal Title
  
  Nature Communications
  
  Volume: 13 Issue: 1 Pages: 3123-3123
- DOI
  10.1038/s41467-022-30861-z
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K08052, KAKENHI-PROJECT-20K16984, KAKENHI-PROJECT-20K22760
[Presentation] 肝細胞癌に対するペプチドワクチン投与症例における抗原特異的細胞傷害性T細胞の表現型と予後の関連2023
- Author(s)
  中河　秀俊　水腰　英四郎　山下　太郎
- Organizer
  JDDW2023
- Data Source
  KAKENHI-PROJECT-22K08052
[Presentation] シングルセルRNAシーケンスを用いた肝細胞癌に対するペプチドワクチンにより誘導される抗原特異的T細胞の解析手法2023
- Author(s)
  中河　秀俊、水腰　英四郎、山下　太郎
- Organizer
  第109回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-22K08052
[Presentation] TUMOR-SPECIFIC IMMUNITY, NOT IRRELEVANT IMMUNITY, CONTRIBUTES TO PROLONGED SURVIVAL IN PEPTIDE-VACCINATED PATIENTS WITH HEPATOCELLULAR CARCINOMA2022
- Author(s)
  Dr. Hidetoshi Nakagawa, Dr. Yuta Tamaru, Dr. Kouki Yamagata and Dr. Eishiro Mizukoshi
- Organizer
  AASLD The Liver Meeting 2022
- Data Source
  KAKENHI-PROJECT-22K08052
[Presentation] 肝がんペプチドワクチン奏効例におけるワクチン特異的・非特異的CD8陽性T細胞の挙動と遺伝子発現解析2022
- Author(s)
  中河秀俊　水腰英四郎　金子周一
- Organizer
  第58回日本肝臓学会総会
- Data Source
  KAKENHI-PROJECT-22K08052
[Presentation] 進行肝細胞癌に対するラジオ波焼灼療法先行アテゾズマブ・ベバシズマブ療法の忍容性の検討と免疫学的解析2022
- Author(s)
  中河　秀俊、山下　竜也、金子　周一
- Organizer
  第108回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-20K22760
[Presentation] 進行癌細胞癌に対するラジオ波焼灼療法先行アテゾズマブ・ベバシズマブ療法の忍容性の検討と免疫学的解析2022
- Author(s)
  中河　秀俊、山下　竜也、金子　周一
- Organizer
  第108回日本消化器病学会総会
- Data Source
  KAKENHI-PROJECT-22K08052
[Presentation] TUMOR-SPECIFIC T CELLS INDUCED BY PEPTIDE VACCINES CONTRIBUTE TO PROLONGED SURVIVALS IN HEPATOCELLULAR CARCINOMA PATIENTS2021
- Author(s)
  Hidetoshi Nakagawa, Eishiro Mizukoshi, Shuichi Kaneko
- Organizer
  AASLD2021
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-20K22760

Nakagawa Hidetoshi 中河 秀俊

中河 秀俊 ナカガワ ヒデトシ

Research Projects

Research Products

Combination of T cell receptor gene therapy and immune checkpoint blockadePrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Antitumor immunity mediated by HLA-E in hepatocellular carcinomaPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

肝臓がん遺伝子治療用T細胞受容体の選択と機能評価Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] Peptide vaccine-treated, long-term surviving cancer patients harbor self-renewing tumor-specific CD8+ T cells2022

Author(s)

Journal Title

DOI

Data Source

[Presentation] 肝細胞癌に対するペプチドワクチン投与症例における抗原特異的細胞傷害性T細胞の表現型と予後の関連2023

Author(s)

Organizer

Data Source

[Presentation] シングルセルRNAシーケンスを用いた肝細胞癌に対するペプチドワクチンにより誘導される抗原特異的T細胞の解析手法2023

Author(s)

Organizer

Data Source

[Presentation] TUMOR-SPECIFIC IMMUNITY, NOT IRRELEVANT IMMUNITY, CONTRIBUTES TO PROLONGED SURVIVAL IN PEPTIDE-VACCINATED PATIENTS WITH HEPATOCELLULAR CARCINOMA2022

Author(s)

Organizer

Data Source

[Presentation] 肝がんペプチドワクチン奏効例におけるワクチン特異的・非特異的CD8陽性T細胞の挙動と遺伝子発現解析2022

Author(s)

Organizer

Data Source

[Presentation] 進行肝細胞癌に対する ラジオ波焼灼療法先行アテゾズマブ・ベバシズマブ療法 の忍容性の検討と免疫学的解析2022

Author(s)

Organizer

Data Source

[Presentation] 進行癌細胞癌に対するラジオ波焼灼療法先行アテゾズマブ・ベバシズマブ療法の忍容性の検討と免疫学的解析2022

Author(s)

Organizer

Data Source

[Presentation] TUMOR-SPECIFIC T CELLS INDUCED BY PEPTIDE VACCINES CONTRIBUTE TO PROLONGED SURVIVALS IN HEPATOCELLULAR CARCINOMA PATIENTS2021

Author(s)

Organizer

Data Source

Nakagawa Hidetoshi 中河秀俊

中河秀俊ナカガワヒデトシ

[Presentation] 進行肝細胞癌に対するラジオ波焼灼療法先行アテゾズマブ・ベバシズマブ療法の忍容性の検討と免疫学的解析2022